172 related articles for article (PubMed ID: 15588224)
21. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
[TBL] [Abstract][Full Text] [Related]
22. Role of interleukin-21 in inflammation and allergy.
Fina D; Fantini MC; Pallone F; Monteleone G
Inflamm Allergy Drug Targets; 2007 Mar; 6(1):63-8. PubMed ID: 17352690
[TBL] [Abstract][Full Text] [Related]
23. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
[TBL] [Abstract][Full Text] [Related]
24. Autoreactive T cells mediate NK cell degeneration in autoimmune disease.
Liu R; Van Kaer L; La Cava A; Price M; Campagnolo DI; Collins M; Young DA; Vollmer TL; Shi FD
J Immunol; 2006 May; 176(9):5247-54. PubMed ID: 16621990
[TBL] [Abstract][Full Text] [Related]
25. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
26. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.
Gharibi T; Majidi J; Kazemi T; Dehghanzadeh R; Motallebnezhad M; Babaloo Z
Immunobiology; 2016 Feb; 221(2):357-67. PubMed ID: 26466984
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.
Leclercq G; Debacker V; de Smedt M; Plum J
J Exp Med; 1996 Aug; 184(2):325-36. PubMed ID: 8760786
[TBL] [Abstract][Full Text] [Related]
28. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.
Vosshenrich CA; Ranson T; Samson SI; Corcuff E; Colucci F; Rosmaraki EE; Di Santo JP
J Immunol; 2005 Feb; 174(3):1213-21. PubMed ID: 15661875
[TBL] [Abstract][Full Text] [Related]
29. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis.
Ma A; Koka R; Burkett P
Annu Rev Immunol; 2006; 24():657-79. PubMed ID: 16551262
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.
Maarof G; Bouchet-Delbos L; Gary-Gouy H; Durand-Gasselin I; Krzysiek R; Dalloul A
Blood; 2010 Mar; 115(9):1718-26. PubMed ID: 19965640
[TBL] [Abstract][Full Text] [Related]
31. A critical role for IL-21 in regulating immunoglobulin production.
Ozaki K; Spolski R; Feng CG; Qi CF; Cheng J; Sher A; Morse HC; Liu C; Schwartzberg PL; Leonard WJ
Science; 2002 Nov; 298(5598):1630-4. PubMed ID: 12446913
[TBL] [Abstract][Full Text] [Related]
32. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
33. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 35: Inhibitory regulator in monocyte-derived dendritic cell maturation and activation.
Chen X; Hao S; Zhao Z; Liu J; Shao Q; Wang F; Sun D; He Y; Gao W; Mao H
Cytokine; 2018 Aug; 108():43-52. PubMed ID: 29571039
[TBL] [Abstract][Full Text] [Related]
35. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.
Lodolce JP; Boone DL; Chai S; Swain RE; Dassopoulos T; Trettin S; Ma A
Immunity; 1998 Nov; 9(5):669-76. PubMed ID: 9846488
[TBL] [Abstract][Full Text] [Related]
36. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.
Herber D; Brown TP; Liang S; Young DA; Collins M; Dunussi-Joannopoulos K
J Immunol; 2007 Mar; 178(6):3822-30. PubMed ID: 17339481
[TBL] [Abstract][Full Text] [Related]
37. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation.
Leonard WJ; Spolski R
Nat Rev Immunol; 2005 Sep; 5(9):688-98. PubMed ID: 16138102
[TBL] [Abstract][Full Text] [Related]
39. The composite cytokine p28/cytokine-like factor 1 sustains B cell proliferation and promotes plasma cell differentiation.
Tormo AJ; Meliani Y; Beaupré LA; Sharma M; Fritz JH; Elson G; Crabé S; Gauchat JF
J Immunol; 2013 Aug; 191(4):1657-65. PubMed ID: 23836062
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 7 receptor-deficient mice lack gammadelta T cells.
Maki K; Sunaga S; Komagata Y; Kodaira Y; Mabuchi A; Karasuyama H; Yokomuro K; Miyazaki JI; Ikuta K
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7172-7. PubMed ID: 8692964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
